Streptococcus milleri bacteremia. Review of 18 episodes;Bacteriemias por el grupo Streptococcus milleri. Análisis de 18 episodios

Revista Clinica Espanola

Volumn 197, Issue 6, 1997, Pages 393-397

  Sanchez Porto A ^a,c   Torres Tortosa, M ^a   Canueto, J ^a   Dominguez M C ^b  

^a Hosp Serv Andaluz Salud La L   (Spain)

^b HOSPITAL PUNTA DE EUROPA   (Spain)

^c NONE   (Spain)

Author keywords

Abscesses; Bacteremia; Cutaneous infection; Diabetes; Streptococcus milleri

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; CROSS INFECTION; DRUG EFFECT; FEMALE; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; NEWBORN; PROSPECTIVE STUDY; SPAIN; STREPTOCOCCUS; STREPTOCOCCUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CROSS INFECTION; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; SPAIN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS;

EID: 0346491075     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Stratton ChW Streptococcus intermedius group. En. Mandell GL Bennett JE, Dolin R, eds Principles and practice of infectious diseases (4th ed). New York, Churchll Livingstone, 1995, 1 861-1.865
2. Parker MT, Ball LC. Streptococci and aerococci associated with systemic infection in man. J Med Microbiol 1976; 9:275-302
3. Gossling J. Occurrence and pathogenicity of the Streptococcus milleri group Rev Infect Dis 1988; 10:257-285.
4. Murray HW, Gross K, Masur H, Roberts RB Serious infections caused by Streptococcus milleri Am J Med 1978; 64 759-764.
5. Shlaes DM, Lerner PI, Wolinsky E, Gopalakrishna KV. Infections due to Lancefield group F and related Streptococci (S. milleri, S. anginosus). Medicine (Baltimore) 1981; 60:197-207.
6. Molina JM, Leport C, Bure A, Wolff M, Michon C, Vilde JL. Cinical and bacterial features of infections caused by Streptococcus milleri. Scand J Infect Dis 1991; 23:659-666.
7. Van der Auwera P Clinical significance of Streptococcus millen Eur J Clin Microbiol 1985; 4:386-390
8. Molina F, Durán MT. Caracteristicas microbiológicas y espectro de infecciones de 108 Streptococcus anginosus aislados. Enferm Infecc Microbiol Clin 1993; 11:304-308
9. Fernández de Quirós B, Teleriti M, Moreno A, Arroyo F. Infecciones clinicas por Streptococcus intermedius Rev Clin Esp 1988; 183:227-231.
10. Jacobs JA, Pietersen HG, Stobbenngh E, Soeters PB. Bacteremia involving the Streptococcus milleri group: analysis of 19 cases. Clin Infect Dis 1994; 19:704-713.
11. Libertin CR, Hermans PE, Washington JA. Beta-hemolytic group F streptococcal bacteremia: a study and review of the literature. Rev Infect Dis 1985; 7:498-503.
12. Tresadern JC, Farrand RJ, Irving MH Streptococcus milleri and surgical sepsis. Ann R Coll Surg Engl 1983; 65:78-79.
13. Gómez-Garcés JL, Alós JI, Cogollos R. Bacteriologic characteristics and antimicrobial susceptibility of 70 clinically significant isolates of Streptococcus milleri group Diagn Microbiol Infect Dis 1994; 19:69-73
14. Flynn CE, Ruoff K, Identification of Streptococcus milleri group isolates to the species level with a commercially available rapid test system. J Clin Microbiol 1995; 33:2.704-2.706.
15. Jorgensen JH, Ferraro MJ, McElmeel ML, Spargo J, Swenson JM, Tenover FC. Detection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test. J Clin Microbiol 1994; 32:159-163.
16. National Committee for Clinical Laboratory Standards. Performance Standars for antimicrobial susceptibility testing. NCCLS document M2-A4. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1990.
17. National Committee for Clinical Laboratory Standars. Performance standards for antimicrobial susceptibility testing. NCCLS document M7-A3. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1993.
18. Grupo de estudio de la bactenemia (Coordinador: F. Martínez-Luengas) Bacteriemia en seis hospitales españoles. Med Clin (Barc) 1986; 86: 221-232
19. McCabe WR, Jackson GG. Gram-negative bacteremia I. Etiology and ecology Arch Intern Med 1962; 110:847-855.
20. a ed). Madrid: Editorial Ciencia 3, SA, 1986; 139 y 236.
21. Guthof, O. Ueber pathogene «vergrünnende Streptokokken»; Streptokokken-Befunde bei dentogenen abszessen und Infiltrateri im bereich der mundhöhle. Zentralbl bakteriol Parasitkde 1956; 166:553-564.
22. Colman G, Williams REO Taxonomy of some human human viridans streptococci. En. Wannamaker LW, Matsen JM. eds. Streptococci and Streptococcal diseases: recognition, understanding and management New York Academic Press, 1972: 281-299.
23. Facklam RR, Tracker LG, Fox B, Enríquez L. Presumptive identification of streptococci with a new test system. J Clin Microbiol 1982; 15:987-990.
24. Coykendall AL, Wesbecher PM, Gustafson KB Streptococcus milleri. Streptococcus constellatus and Streptococcus intermedius are later synonimus of Streptococcus anginosus. Int J Syst Bacteriol 1987; 37:222-228.
25. Whiley RA, Beighton D. Emended descriptions and recognition of Streptococcus constellatus, Streptococcus intermedius and Streptococcus anginosus as distinct species. Int J Syst Bacteriol 1991; 41:1-5
26. Salavert M, Rodriguez-Carballeira M, Gómez L, Dalmau D, Xercavins M, Freixas N Garau J Infecciones por el grupo Streptococcus milleri. VI Congreso Nacional de la SEIMC Valencia, 1994, comunicación 540.
27. Whiley RA, Beighton D, Winstanley TG, Fraser HY, Hardie JM, Streptococcus intermedius. Streptococcus constellatus and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections. J Clin Microbiol 1992; 30:243-244.
28. Awada A, Van der Auwera P, Meunier F, Daneau D, Klastersky J. Streptococcal and enterococcal bacteremia in patients with cancer. Clin Infect Dis 1992; 15:33-48.
29. McMahon MM, Bistrian BR. Host defenses and susceptibility to infection in patients with diabetes mellitus. En: Eliopoulos GM, ed Infections in diabetes mellitus. Infectious Diseases Clinics of North America Philadelphia: WB Saunders Company. 1995; 9:1-9.
30. Ascaso JF, Arbona C, Alcácer F, Serrano S, Hernändez A, Martínez-Valls J. Infección en la diabetes: relatión con el grado de control metabólico y la malnutrición proteica Med Clín (Barc) 1990; 95:721-724.
31. Carton JA, Maradona JA, Nuno FJ, Fernández-Álvarez R, Pérez-González F, Asensi V. Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients. Eur J Med 1992; 1:281-287
32. Summanen PH, Talan DA, Strong C, et al. Bacteriology of skin and soft-tissue infections, comparison of infections in intravenous drug users and individuals with no history of intravenous drug use. Clin Infect Dis 1995; 20 (suppl 2):S279-S282.
33. Stocker E, Cortés E, Pema K, Meza A, Verghese A. Streptococcus milleri as a cause of antecubital abscess and bacteremia in intravenous drug abusers. South Med J 1994; 87:95-96
34. Barnham M. Invasive Streptococcal infections in the era before the acquired immune deficiency syndrome: a 10 years' compilation of patients with Streptococcal bacteremia in North Yorkshire. J Infect 1989; 18:231-248.
35. Chua D, Reinhart HH, Sobel JD. Liver abscess by Streptococcus milleri. Rev Infect Dis 1989; 11:197-202.
36. Gelfand MS, Hodgkiss T, Simmons BP. Multiple hepatic abscesses caused by Streptococcus milleri in association with an intrauterine device Rev Infect Dis 1989; 11:983-987.
37. Marshall R, Kaufman AK. Production of deoxyribonuclease, ribonuclease, coagulase and hemolysins by anaerobic gram-positive cocci J Clin Microbiol 1981; 13:787-788.
38. Ruoff KL, Ferraro MJ Hydrolytic enzymes of Streptococcus milleri. J Clin Microbiol 1987; 25:1.645-1 647.
39. Jacobs JA. Stobberingh EE Hydrolytic enzymes of Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius in relation to infection. Eur J Clin Microbiol Infect Dis 1995; 14:818-820.